首页> 外文期刊>Journal of Clinical Microbiology >Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens.
【24h】

Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens.

机译:与产气荚膜梭状芽孢杆菌临床分离株相比,梭状芽孢梭菌,无毒梭状芽孢杆菌和球孢梭状芽孢杆菌临床分离株的鉴定和抗药性模式。

获取原文
           

摘要

Clostridium ramosum, C. innocuum, and C. clostridioforme are frequently isolated from clinical specimens including blood. Because of Gram stain variability, a lack of spores, and atypical colonial morphology, identification of these species is often difficult. Three anaerobe identification kits were evaluated for their abilities to identify these species. For comparison, 11 strains of C. perfringens were evaluated in parallel. By using profile numbers and codebooks, the correct genus and species were identified, as follows: with the RapID ANA II kit, 100% (20 of 20) of C. ramosum isolates, 24% (5 of 21) of C. innocuum isolates, and 50% (10 of 20) of C. clostridioforme isolates; with the AnIDent kit, 60% (12 of 20) of C. ramosum isolates, 28% (6 of 21) of C. innocuum isolates, and 90% (18 of 20) of C. clostridioforme isolates; with the ATB32A kit, 70% (14 of 20) of C. ramosum isolates, 0% (0 of 21) of C. innocuum isolates, and 40% (8 of 20) of C. clostridioforme isolates. Profile numbers that overlapped several species were obtained as follows: with the RapID ANA II kit, 0% of C. ramosum isolates, 76% of C. innocuum isolates, and 40% of C. clostridioforme isolates; with the AnIDent kit 40% of C. ramosum isolates, 62% of C. innocuum isolates, and 5% of C. clostridioforme isolates; with the ATB32A kit, 15% of C. ramosum isolates, 52% of C. innocuum isolates, and 25% of C. clostridioforme isolates. One strain of C. innocuum was misidentified by the AnIDent kit, and the remainder yielded profile numbers that were not listed in the codebooks. The MICs of 11 antimicrobial agents including penicillin G, metronidazole, clindamycin, cefoxitin, cefotetan, imipenem, meropenem, amoxicillin-clavulanate, ampicillin-sulbactam, piperacillin-tazobactam, and vancomycin were determined by the agar dilution method. All C. perfringens strains were susceptible to all antimicrobial agents tested. Various levels of resistance to cefoxitin, cefotetan, and penicillin G were noted with C. ramosum, C. clostridioforme, and C. innocuum. In addition, resistance to clindamycin was noted with C. ramosum (5%) and C. innocuum (10%). Most strains of C. innocuum were only moderately susceptible to vancomycin (MIC at which 90% of strains are inhibited, 4 micrograms/ml).
机译:通常从包括血液在内的临床标本中分离出产气荚膜梭状芽孢杆菌,无毒梭状芽孢杆菌和梭状梭状芽孢杆菌。由于革兰氏染色的变异性,孢子的缺乏和非典型的殖民地形态,这些物种的鉴定通常很困难。对三种厌氧菌鉴定试剂盒的鉴定能力进行了评估。为了比较,平行评估了11株产气荚膜梭菌。通过使用配置文件编号和密码本,可以识别出正确的属和种,如下所示:使用RapID ANA II试剂盒,可以分离出100%(20个中的20个)的C. ramosum分离物,24%(21个中的5个)的C. innocuum分离物。 ,以及50%(20的10)的梭状梭菌分离株;使用AnIDent试剂盒,将60%(20个中的12个)的C. ramosum分离物,28%(21个中的6个)的C. innocuum分离物和90%(20个中的18个)的梭状梭菌分离物;使用ATB32A试剂盒,将有70%(20个中的14个)的C. ramosum分离株,0%(21个中的0个)的C. innocuum分离株和40%(20个中的8个)梭状梭状芽胞杆菌。重叠数个物种的谱图编号如下:使用RapID ANA II试剂盒,0%的C. ramosum分离物,76%的C. innocuum分离物和40%的梭状梭菌分离物;使用AnIDent试剂盒,40%的C. ramosum分离株,62%的C. innocuum分离株和5%的梭状梭菌分离株;使用ATB32A套件时,有15%的C. ramosum分离株,52%的C. innocuum分离株和25%的梭状梭状芽胞杆菌分离株。 AnIDent试剂盒错误地鉴定了一种无毒梭状芽胞杆菌,其余菌株产生的谱号未在密码本中列出。通过琼脂稀释法测定了11种抗菌药物的MIC,包括青霉素G,甲硝唑,克林霉素,头孢西丁,头孢替坦,亚胺培南,美罗培南,阿莫西林-克拉维酸盐,氨苄青霉素-舒巴坦,哌拉西林-他唑巴坦和万古霉素。所有产气荚膜梭菌菌株均对所有测试的抗菌剂敏感。注意到C. ramosum,C。clostridioforme和C. innocuum对头孢西丁,头孢替坦和青霉素G有不同程度的耐药性。另外,对C. ramosum(5%)和C. innocuum(10%)观察到对克林霉素的抗性。大多数无毒梭状芽孢杆菌菌株仅对万古霉素敏感(MIC抑制90%,MIC为4微克/毫升)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号